Drugs / Equine F(ab')2 antivenom
Equine F(ab')2 antivenom
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01336660 | Jul → Nov 2018 | scorpion envenomation | Instituto Bioclon S.A. de C.V. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Equine F(ab')2 antivenom | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01336660 ↗ |
| Modality | Protein / enzyme biologic | “This antivenom is a third generation F(ab')2 "fabotherapeutic" agent.” NCT01336660 ↗ |
| Route | Intravenous | “It is administered intravenously” NCT01336660 ↗ |